Post-approval studies (Phase 4)Study completedNCT02939872
What this trial is testing
Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events
Who this might be right for
Percutaneous Transluminal Coronary AngioplastyCoronary Disease
Seung-Jung Park 238